CN Stock MarketDetailed Quotes

002100 Tecon Biology Co.Ltd

Watchlist
  • 6.95
  • -0.13-1.84%
Market Closed Dec 13 15:00 CST
9.49BMarket Cap-32.33P/E (TTM)

Tecon Biology Co.Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-5.06%3.65B
-25.54%2.86B
-31.02%2.68B
-15.00%2.82B
-35.08%3.84B
57.11%3.84B
67.53%3.89B
-3.05%3.32B
96.68%5.92B
37.29%2.45B
Transactional financial assets
--10.55M
-99.48%522.51K
--472.63K
-99.93%473.08K
----
--100M
----
--650.94M
----
----
Notes receivable and accounts receivable
-8.40%749.25M
-16.17%613.5M
-3.53%712.26M
7.93%430.75M
7.39%817.99M
33.91%731.84M
27.87%738.31M
26.94%399.1M
35.20%761.72M
17.61%546.5M
-Notes receivable
348.98%73.9M
-32.03%13.47M
67.52%26.64M
-11.60%9.62M
654.60%16.46M
306.30%19.82M
6.78%15.9M
30.07%10.88M
-79.03%2.18M
11.89%4.88M
-Accounts receivable
-15.74%675.36M
-15.73%600.02M
-5.09%685.63M
8.48%421.13M
5.53%801.54M
31.46%712.02M
28.43%722.41M
26.86%388.22M
37.35%759.54M
17.67%541.62M
Other receivables (including interest and dividends)
5.62%371.11M
-5.95%283.77M
-16.98%256M
-13.60%259.14M
3.05%351.37M
-2.96%301.73M
-17.93%308.36M
-8.72%299.94M
-14.27%340.97M
-18.31%310.92M
-Other receivable
----
-5.95%283.77M
----
----
----
-2.96%301.73M
----
-8.72%299.94M
----
-18.31%310.92M
Advance payment
131.55%862.5M
-20.41%316.22M
-27.30%484.52M
-65.96%386.57M
-52.75%372.48M
-23.27%397.31M
-24.24%666.45M
42.71%1.14B
13.60%788.37M
-23.40%517.77M
Inventories
-7.40%3B
-15.59%4.32B
-30.13%4.74B
-24.63%4.55B
-17.73%3.24B
-0.22%5.12B
16.73%6.78B
15.07%6.04B
30.87%3.93B
7.45%5.13B
Receivable financing
--11.28M
--2.29M
----
397.94%13.53M
----
----
----
1,371.03%2.72M
----
----
Other current assets
24.20%414.37M
2.55%483.24M
-19.20%479.93M
-11.04%475.88M
-17.10%333.62M
-4.24%471.21M
14.09%593.93M
7.35%534.95M
44.55%402.43M
35.72%492.07M
Total current assets
1.71%9.12B
-18.97%8.9B
-27.97%9.36B
-27.71%8.96B
-26.23%8.96B
16.21%10.98B
23.87%12.99B
16.81%12.4B
52.71%12.15B
11.36%9.45B
Non Current assets
Long-term equity investment
-13.59%33.56M
-12.16%33.83M
74.83%37.34M
-65.76%36.11M
-70.76%38.84M
-69.39%38.51M
-82.80%21.36M
-2.43%105.45M
10.88%132.83M
10.53%125.8M
Fixed assets
----
3.84%5.28B
----
----
----
3.70%5.08B
----
18.10%5.13B
----
28.09%4.9B
Constru in process
----
0.69%842.66M
----
----
----
86.76%836.88M
----
-52.47%425.14M
----
-42.20%448.09M
Productive biological assets
-22.75%280.75M
-19.38%292.7M
-22.07%295.55M
-10.65%320.76M
-5.62%363.42M
-17.58%363.08M
-7.13%379.26M
0.79%359M
14.20%385.07M
21.82%440.5M
Intangible assets
15.56%389.63M
13.12%385.71M
40.79%384.78M
34.44%360.84M
22.89%337.17M
22.06%340.96M
-2.63%273.3M
-1.36%268.4M
11.87%274.36M
11.73%279.34M
Development expenditure
-65.10%3.16M
-89.57%750K
-52.15%6.21M
-9.52%7.01M
-82.06%9.06M
-85.09%7.19M
-55.59%12.98M
--7.75M
72.71%50.49M
64.99%48.24M
Goodwill
-17.02%178.48M
-17.02%178.48M
-47.96%178.48M
702.42%178.48M
867.07%215.1M
867.07%215.1M
1,441.92%342.96M
0.00%22.24M
-3.54%22.24M
-3.54%22.24M
Long deferred expense
-13.80%18.86M
-3.74%20.84M
12.31%23.45M
4.18%24.04M
-3.02%21.88M
-15.07%21.65M
-7.11%20.87M
-11.83%23.08M
-63.49%22.57M
-33.56%25.5M
Deferred tax assets
101.40%92.26M
172.55%74.66M
72.12%74.12M
84.56%72.18M
154.77%45.81M
49.64%27.39M
115.31%43.06M
143.58%39.11M
64.94%17.98M
62.78%18.31M
Usufruct assets
5.35%608.22M
13.07%631.36M
16.12%652.15M
14.91%623.65M
15.81%577.34M
18.20%558.38M
15.15%561.64M
10.90%542.71M
21.81%498.52M
25.61%472.42M
Other non current assets
-30.29%29.23M
-57.13%17.97M
-99.20%269.78K
-58.77%19.34M
--41.93M
--41.92M
--33.69M
3,561.01%46.9M
----
----
Total non current assets
1.98%7.81B
2.96%7.75B
5.76%7.81B
11.84%7.79B
12.32%7.65B
11.09%7.53B
11.83%7.38B
6.73%6.97B
10.45%6.82B
16.82%6.78B
Total assets
1.84%16.92B
-10.05%16.65B
-15.75%17.17B
-13.48%16.75B
-12.38%16.62B
14.07%18.51B
19.22%20.37B
12.97%19.36B
34.25%18.96B
13.58%16.23B
Liabilities
Current liabilities
Short term loan
129.68%2.54B
1.60%2.7B
-16.66%3.18B
3.26%3.32B
-64.90%1.1B
-17.96%2.65B
0.28%3.82B
-19.75%3.21B
18.53%3.15B
51.15%3.23B
Notes payable and accounts payable
-4.16%612.29M
6.27%580.5M
25.42%653.57M
14.07%697.12M
23.17%638.84M
26.31%546.26M
-7.61%521.13M
31.36%611.11M
7.44%518.67M
-13.99%432.48M
-Notes payable
76.47%14.85M
463.86%23.79M
--21.08M
--5.3M
--8.41M
--4.22M
----
----
----
----
-Accounts payable
-5.23%597.44M
2.71%556.71M
21.37%632.49M
13.21%691.82M
21.55%630.42M
25.33%542.04M
-7.61%521.13M
31.36%611.11M
10.18%518.67M
-11.89%432.48M
Contract liabilities
112.15%735.34M
-32.28%498.67M
-1.51%481.41M
-6.82%440.23M
-33.47%346.61M
28.67%736.36M
-35.85%488.79M
-30.64%472.48M
24.38%520.94M
-35.03%572.29M
Advance receipts
----
----
----
-41.79%48.51K
----
----
----
-82.39%83.33K
----
----
Salaries payable
-4.07%233.7M
-11.65%220.16M
-14.11%267.63M
-5.01%297.56M
-12.82%243.63M
-11.12%249.18M
5.14%311.59M
-11.95%313.24M
-5.78%279.45M
-3.05%280.34M
Taxs payable
18.11%33.92M
-54.90%9.1M
66.33%40.72M
29.09%31.78M
172.86%28.72M
29.46%20.18M
-10.61%24.48M
32.71%24.62M
-57.41%10.53M
-66.18%15.59M
Other payable (including interest and dividends)
0.10%769.96M
-8.81%693.75M
-29.92%693.29M
-0.38%731.35M
5.82%769.22M
14.02%760.8M
77.35%989.22M
21.62%734.11M
34.57%726.93M
13.54%667.23M
-Dividend payable
----
----
----
----
----
0.00%48.3M
----
-85.94%2.92M
----
-17.42%48.3M
-Other payable
----
-2.63%693.75M
----
----
----
15.12%712.5M
----
25.45%731.19M
----
16.97%618.93M
Non current liabilities due within one year
-52.08%1.09B
4.99%1.6B
57.44%1.71B
104.82%1.49B
277.40%2.27B
102.89%1.53B
93.94%1.08B
-2.00%726.68M
-20.48%602.73M
19.10%752.09M
Other current liabilities
148.26%150.54M
-19.90%64.23M
-15.17%66.01M
-23.21%81.31M
-8.18%60.64M
20.84%80.2M
0.57%77.81M
17.06%105.9M
20.47%66.04M
-4.71%66.37M
Total current liabilities
12.73%6.16B
-3.16%6.36B
-3.00%7.1B
14.16%7.09B
-7.12%5.47B
8.98%6.57B
8.84%7.32B
-10.95%6.21B
12.52%5.89B
17.15%6.03B
Current liabilities
Long term loan
-7.55%1.64B
-41.99%1.48B
-45.79%1.56B
-60.89%1.23B
-38.60%1.77B
24.82%2.55B
27.68%2.88B
59.52%3.13B
44.20%2.89B
5.58%2.05B
Bonds payable
----
----
----
----
----
----
----
----
-4.72%90.71M
-4.55%91.23M
Deferred tax liabilities
7.65%17.82M
2,310.20%17.22M
2,374.31%17.68M
2,020.24%18.13M
4,135.14%16.55M
82.80%714.38K
82.80%714.38K
14.46%855.3K
-13.05%390.8K
-13.05%390.8K
Long term deferred income
29.47%141.35M
48.88%144.51M
60.50%144.54M
63.74%143.29M
30.71%109.17M
26.18%97.07M
17.40%90.06M
8.01%87.51M
1.46%83.52M
-10.05%76.93M
Lease liabilities
5.83%480.09M
32.60%494.54M
27.32%409.42M
19.96%362.93M
26.62%453.64M
6.28%372.97M
-5.91%321.55M
2.70%302.53M
9.88%358.27M
35.03%350.93M
Total non current liabilities
-3.14%2.28B
-29.32%2.14B
-35.21%2.13B
-50.35%1.75B
-31.23%2.35B
17.89%3.02B
18.98%3.29B
44.72%3.52B
36.46%3.42B
7.82%2.56B
Total liabilities
7.95%8.44B
-11.40%8.5B
-13.00%9.23B
-9.20%8.84B
-15.98%7.82B
11.64%9.6B
11.79%10.61B
3.46%9.73B
20.28%9.31B
14.20%8.6B
Shareholders equity
Paid-in capital
0.76%1.37B
0.77%1.37B
0.79%1.37B
0.81%1.37B
0.05%1.36B
0.04%1.35B
0.04%1.35B
0.04%1.35B
25.83%1.35B
25.83%1.35B
Other equity instruments
----
----
----
----
-6.48%3.37M
-4.89%3.45M
-4.55%3.52M
-4.47%3.6M
-5.10%3.6M
-4.91%3.63M
Capital reserve funds
0.70%3.94B
0.75%3.94B
0.15%3.94B
2.60%3.94B
3.02%3.91B
18.49%3.91B
19.24%3.94B
16.34%3.84B
149.17%3.8B
118.01%3.3B
Surplus reserve funds
6.31%466.77M
6.31%466.77M
6.31%466.77M
6.31%466.77M
58.80%439.08M
58.80%439.08M
58.80%439.08M
59.69%439.08M
21.66%276.49M
21.66%276.49M
Retained profit
-22.38%1.11B
-44.74%823.8M
-72.26%635.46M
-74.39%581.39M
-42.16%1.43B
-29.79%1.49B
6.50%2.29B
4.73%2.27B
-10.32%2.48B
-33.61%2.12B
Other composite income
1,117.36%54.99M
-54.34%10.28M
-115.39%-1.74M
3,494.81%51.12M
120.59%4.52M
160.57%22.52M
112.70%11.27M
115.50%1.42M
-163.54%-21.94M
-332.78%-37.18M
Ordinary risk reserve funds
0.00%3.85M
0.00%3.85M
0.00%3.85M
0.00%3.85M
11.53%3.85M
11.53%3.85M
11.53%3.85M
11.53%3.85M
35.11%3.46M
35.11%3.46M
Shareholders equity without minority interests
-2.91%6.95B
-8.51%6.61B
-20.25%6.41B
-19.01%6.41B
-9.38%7.15B
2.86%7.23B
14.83%8.04B
11.52%7.92B
40.14%7.89B
16.35%7.03B
Minority interests
-6.59%1.53B
-8.89%1.54B
-11.69%1.53B
-12.28%1.5B
-6.76%1.64B
178.21%1.69B
187.09%1.73B
170.08%1.71B
133.61%1.76B
-16.11%607.09M
Total shareholder equity
-3.60%8.48B
-8.58%8.15B
-18.73%7.94B
-17.81%7.91B
-8.90%8.8B
16.81%8.92B
28.48%9.77B
24.54%9.63B
51.18%9.66B
12.88%7.63B
Total liabilityies and equity
1.84%16.92B
-10.05%16.65B
-15.75%17.17B
-13.48%16.75B
-12.38%16.62B
14.07%18.51B
19.22%20.37B
12.97%19.36B
34.25%18.96B
13.58%16.23B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -5.06%3.65B-25.54%2.86B-31.02%2.68B-15.00%2.82B-35.08%3.84B57.11%3.84B67.53%3.89B-3.05%3.32B96.68%5.92B37.29%2.45B
Transactional financial assets --10.55M-99.48%522.51K--472.63K-99.93%473.08K------100M------650.94M--------
Notes receivable and accounts receivable -8.40%749.25M-16.17%613.5M-3.53%712.26M7.93%430.75M7.39%817.99M33.91%731.84M27.87%738.31M26.94%399.1M35.20%761.72M17.61%546.5M
-Notes receivable 348.98%73.9M-32.03%13.47M67.52%26.64M-11.60%9.62M654.60%16.46M306.30%19.82M6.78%15.9M30.07%10.88M-79.03%2.18M11.89%4.88M
-Accounts receivable -15.74%675.36M-15.73%600.02M-5.09%685.63M8.48%421.13M5.53%801.54M31.46%712.02M28.43%722.41M26.86%388.22M37.35%759.54M17.67%541.62M
Other receivables (including interest and dividends) 5.62%371.11M-5.95%283.77M-16.98%256M-13.60%259.14M3.05%351.37M-2.96%301.73M-17.93%308.36M-8.72%299.94M-14.27%340.97M-18.31%310.92M
-Other receivable -----5.95%283.77M-------------2.96%301.73M-----8.72%299.94M-----18.31%310.92M
Advance payment 131.55%862.5M-20.41%316.22M-27.30%484.52M-65.96%386.57M-52.75%372.48M-23.27%397.31M-24.24%666.45M42.71%1.14B13.60%788.37M-23.40%517.77M
Inventories -7.40%3B-15.59%4.32B-30.13%4.74B-24.63%4.55B-17.73%3.24B-0.22%5.12B16.73%6.78B15.07%6.04B30.87%3.93B7.45%5.13B
Receivable financing --11.28M--2.29M----397.94%13.53M------------1,371.03%2.72M--------
Other current assets 24.20%414.37M2.55%483.24M-19.20%479.93M-11.04%475.88M-17.10%333.62M-4.24%471.21M14.09%593.93M7.35%534.95M44.55%402.43M35.72%492.07M
Total current assets 1.71%9.12B-18.97%8.9B-27.97%9.36B-27.71%8.96B-26.23%8.96B16.21%10.98B23.87%12.99B16.81%12.4B52.71%12.15B11.36%9.45B
Non Current assets
Long-term equity investment -13.59%33.56M-12.16%33.83M74.83%37.34M-65.76%36.11M-70.76%38.84M-69.39%38.51M-82.80%21.36M-2.43%105.45M10.88%132.83M10.53%125.8M
Fixed assets ----3.84%5.28B------------3.70%5.08B----18.10%5.13B----28.09%4.9B
Constru in process ----0.69%842.66M------------86.76%836.88M-----52.47%425.14M-----42.20%448.09M
Productive biological assets -22.75%280.75M-19.38%292.7M-22.07%295.55M-10.65%320.76M-5.62%363.42M-17.58%363.08M-7.13%379.26M0.79%359M14.20%385.07M21.82%440.5M
Intangible assets 15.56%389.63M13.12%385.71M40.79%384.78M34.44%360.84M22.89%337.17M22.06%340.96M-2.63%273.3M-1.36%268.4M11.87%274.36M11.73%279.34M
Development expenditure -65.10%3.16M-89.57%750K-52.15%6.21M-9.52%7.01M-82.06%9.06M-85.09%7.19M-55.59%12.98M--7.75M72.71%50.49M64.99%48.24M
Goodwill -17.02%178.48M-17.02%178.48M-47.96%178.48M702.42%178.48M867.07%215.1M867.07%215.1M1,441.92%342.96M0.00%22.24M-3.54%22.24M-3.54%22.24M
Long deferred expense -13.80%18.86M-3.74%20.84M12.31%23.45M4.18%24.04M-3.02%21.88M-15.07%21.65M-7.11%20.87M-11.83%23.08M-63.49%22.57M-33.56%25.5M
Deferred tax assets 101.40%92.26M172.55%74.66M72.12%74.12M84.56%72.18M154.77%45.81M49.64%27.39M115.31%43.06M143.58%39.11M64.94%17.98M62.78%18.31M
Usufruct assets 5.35%608.22M13.07%631.36M16.12%652.15M14.91%623.65M15.81%577.34M18.20%558.38M15.15%561.64M10.90%542.71M21.81%498.52M25.61%472.42M
Other non current assets -30.29%29.23M-57.13%17.97M-99.20%269.78K-58.77%19.34M--41.93M--41.92M--33.69M3,561.01%46.9M--------
Total non current assets 1.98%7.81B2.96%7.75B5.76%7.81B11.84%7.79B12.32%7.65B11.09%7.53B11.83%7.38B6.73%6.97B10.45%6.82B16.82%6.78B
Total assets 1.84%16.92B-10.05%16.65B-15.75%17.17B-13.48%16.75B-12.38%16.62B14.07%18.51B19.22%20.37B12.97%19.36B34.25%18.96B13.58%16.23B
Liabilities
Current liabilities
Short term loan 129.68%2.54B1.60%2.7B-16.66%3.18B3.26%3.32B-64.90%1.1B-17.96%2.65B0.28%3.82B-19.75%3.21B18.53%3.15B51.15%3.23B
Notes payable and accounts payable -4.16%612.29M6.27%580.5M25.42%653.57M14.07%697.12M23.17%638.84M26.31%546.26M-7.61%521.13M31.36%611.11M7.44%518.67M-13.99%432.48M
-Notes payable 76.47%14.85M463.86%23.79M--21.08M--5.3M--8.41M--4.22M----------------
-Accounts payable -5.23%597.44M2.71%556.71M21.37%632.49M13.21%691.82M21.55%630.42M25.33%542.04M-7.61%521.13M31.36%611.11M10.18%518.67M-11.89%432.48M
Contract liabilities 112.15%735.34M-32.28%498.67M-1.51%481.41M-6.82%440.23M-33.47%346.61M28.67%736.36M-35.85%488.79M-30.64%472.48M24.38%520.94M-35.03%572.29M
Advance receipts -------------41.79%48.51K-------------82.39%83.33K--------
Salaries payable -4.07%233.7M-11.65%220.16M-14.11%267.63M-5.01%297.56M-12.82%243.63M-11.12%249.18M5.14%311.59M-11.95%313.24M-5.78%279.45M-3.05%280.34M
Taxs payable 18.11%33.92M-54.90%9.1M66.33%40.72M29.09%31.78M172.86%28.72M29.46%20.18M-10.61%24.48M32.71%24.62M-57.41%10.53M-66.18%15.59M
Other payable (including interest and dividends) 0.10%769.96M-8.81%693.75M-29.92%693.29M-0.38%731.35M5.82%769.22M14.02%760.8M77.35%989.22M21.62%734.11M34.57%726.93M13.54%667.23M
-Dividend payable --------------------0.00%48.3M-----85.94%2.92M-----17.42%48.3M
-Other payable -----2.63%693.75M------------15.12%712.5M----25.45%731.19M----16.97%618.93M
Non current liabilities due within one year -52.08%1.09B4.99%1.6B57.44%1.71B104.82%1.49B277.40%2.27B102.89%1.53B93.94%1.08B-2.00%726.68M-20.48%602.73M19.10%752.09M
Other current liabilities 148.26%150.54M-19.90%64.23M-15.17%66.01M-23.21%81.31M-8.18%60.64M20.84%80.2M0.57%77.81M17.06%105.9M20.47%66.04M-4.71%66.37M
Total current liabilities 12.73%6.16B-3.16%6.36B-3.00%7.1B14.16%7.09B-7.12%5.47B8.98%6.57B8.84%7.32B-10.95%6.21B12.52%5.89B17.15%6.03B
Current liabilities
Long term loan -7.55%1.64B-41.99%1.48B-45.79%1.56B-60.89%1.23B-38.60%1.77B24.82%2.55B27.68%2.88B59.52%3.13B44.20%2.89B5.58%2.05B
Bonds payable ---------------------------------4.72%90.71M-4.55%91.23M
Deferred tax liabilities 7.65%17.82M2,310.20%17.22M2,374.31%17.68M2,020.24%18.13M4,135.14%16.55M82.80%714.38K82.80%714.38K14.46%855.3K-13.05%390.8K-13.05%390.8K
Long term deferred income 29.47%141.35M48.88%144.51M60.50%144.54M63.74%143.29M30.71%109.17M26.18%97.07M17.40%90.06M8.01%87.51M1.46%83.52M-10.05%76.93M
Lease liabilities 5.83%480.09M32.60%494.54M27.32%409.42M19.96%362.93M26.62%453.64M6.28%372.97M-5.91%321.55M2.70%302.53M9.88%358.27M35.03%350.93M
Total non current liabilities -3.14%2.28B-29.32%2.14B-35.21%2.13B-50.35%1.75B-31.23%2.35B17.89%3.02B18.98%3.29B44.72%3.52B36.46%3.42B7.82%2.56B
Total liabilities 7.95%8.44B-11.40%8.5B-13.00%9.23B-9.20%8.84B-15.98%7.82B11.64%9.6B11.79%10.61B3.46%9.73B20.28%9.31B14.20%8.6B
Shareholders equity
Paid-in capital 0.76%1.37B0.77%1.37B0.79%1.37B0.81%1.37B0.05%1.36B0.04%1.35B0.04%1.35B0.04%1.35B25.83%1.35B25.83%1.35B
Other equity instruments -----------------6.48%3.37M-4.89%3.45M-4.55%3.52M-4.47%3.6M-5.10%3.6M-4.91%3.63M
Capital reserve funds 0.70%3.94B0.75%3.94B0.15%3.94B2.60%3.94B3.02%3.91B18.49%3.91B19.24%3.94B16.34%3.84B149.17%3.8B118.01%3.3B
Surplus reserve funds 6.31%466.77M6.31%466.77M6.31%466.77M6.31%466.77M58.80%439.08M58.80%439.08M58.80%439.08M59.69%439.08M21.66%276.49M21.66%276.49M
Retained profit -22.38%1.11B-44.74%823.8M-72.26%635.46M-74.39%581.39M-42.16%1.43B-29.79%1.49B6.50%2.29B4.73%2.27B-10.32%2.48B-33.61%2.12B
Other composite income 1,117.36%54.99M-54.34%10.28M-115.39%-1.74M3,494.81%51.12M120.59%4.52M160.57%22.52M112.70%11.27M115.50%1.42M-163.54%-21.94M-332.78%-37.18M
Ordinary risk reserve funds 0.00%3.85M0.00%3.85M0.00%3.85M0.00%3.85M11.53%3.85M11.53%3.85M11.53%3.85M11.53%3.85M35.11%3.46M35.11%3.46M
Shareholders equity without minority interests -2.91%6.95B-8.51%6.61B-20.25%6.41B-19.01%6.41B-9.38%7.15B2.86%7.23B14.83%8.04B11.52%7.92B40.14%7.89B16.35%7.03B
Minority interests -6.59%1.53B-8.89%1.54B-11.69%1.53B-12.28%1.5B-6.76%1.64B178.21%1.69B187.09%1.73B170.08%1.71B133.61%1.76B-16.11%607.09M
Total shareholder equity -3.60%8.48B-8.58%8.15B-18.73%7.94B-17.81%7.91B-8.90%8.8B16.81%8.92B28.48%9.77B24.54%9.63B51.18%9.66B12.88%7.63B
Total liabilityies and equity 1.84%16.92B-10.05%16.65B-15.75%17.17B-13.48%16.75B-12.38%16.62B14.07%18.51B19.22%20.37B12.97%19.36B34.25%18.96B13.58%16.23B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Sigma Certified Public Accountants (Special General Partnership)------Sigma Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme The Pet Economy
The Pet Economy
Intraday-0.50%
Transgenic
Transgenic
Intraday-0.71%
Pork
Pork
Intraday-1.63%